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DOI 10.1002/ajmg.a.36893Persons with 22q11.2 deletion syndrome (22q11.2DS) are char-
acterized inter alia by facial dysmorphology and greatly in-
creased risk for psychotic illness. Recent studies indicate facial
dysmorphology in adults with schizophrenia. This study eval-
uates the extent towhich the facial dysmorphology of 22q11.2DS
is similar to or different from that evident in schizophrenia.
Twenty-one 22q11.2DS-sibling control pairs were assessed using
3D laser surface imaging.Geometricmorphometricswas applied
to 30 anatomical landmarks, 480 geometrically homologous
semi-landmarks on curves and 1720 semi-landmarks interpolat-
ed on each 3D facial surface. Principal component (PC) analysis
of overall shape space indicated PC2 to strongly distinguish
22q11.2DS from controls. Visualization of PC2 indicated
22q11.2DS and schizophrenia to be similar in terms of overall
widening of the upper face, lateral displacement of the eyes/
orbits, prominence of the cheeks, narrowing of the lower face,
narrowing of nasal prominences and posterior displacement of
the chin; they differed in terms of facial length (increased in
22q11.2DS, decreased in schizophrenia), mid-face and nasal
prominences (displaced upwards and outwards in 22q11.2DS,
less prominent in schizophrenia); lips (more prominent in
22q11.2DS; less prominent in schizophrenia) and mouth
(open mouth posture in 22q11.2DS; closed mouth posture in
schizophrenia). These findings directly implicate dysmorpho-
genesis in a cerebral-craniofacial domain that is common
to 22q11.2DS and schizophrenia and which may repay
further clinical and genetic interrogation in relation to the
developmental origins of psychotic illness.
 2015 Wiley Periodicals, Inc.
Key words: 22q11.2 deletion syndrome; velocardiofacial syn-
drome; schizophrenia; craniofacial dysmorphology; 3D laser
surface imaging; geometric morphometrics2015 Wiley Periodicals, Inc.INTRODUCTION
Chromosome 22q11.2 deletion syndrome (22q11.2DS), also
known as velocardiofacial syndrome (VCFS) or DiGeorge syn-
drome, is the most frequently occurring chromosomal microde-
letion syndrome in humans, with an estimated incidence of 1 in
4,000 live births [Goldberg et al., 1993; Robin and Shprintzen,
2005]. This syndrome comprises multiple abnormalities, with an
extensive and variable phenotype with over 180 clinical features;
common abnormalities include speech and palatal anomalies,529
530 AMERICAN JOURNAL OF MEDICAL GENETICS PART Acardiac outflow tract defects, immune disorders, learning difficul-
ties, psychiatric disorders and a characteristic facial dysmorphology
[Kobrynski and Sullivan, 2007; Shprintzen, 2008]. There is a large
body of evidence to indicate an unequivocal association between
22q11.2DS and risk for psychotic illness, with approximately 25%
of adults with 22q11.2DS developing psychosis [Murphy et al.,
1999;Murphy, 2002; Bassett et al., 2005]. Anomalies in craniofacial
and cardiac structures evident in 22q11.2DS, together with psy-
chotic psychopathology, may reflect abnormal neural crest migra-
tion and subsequent mal-development; thus, a gene [or genes]
within the 22q11 region may be involved in neural crest migration
and/or differentiation, such that haploinsufficiency of the gene(s)
may disrupt development, leading to multiple tissue and organ
anomalies [Walker and Trainor, 2006; Aggarwal and Morrow,
2008; Momma, 2010].
Early embryological developmental abnormalities may be in-
volved in the etiologyofpsychosis, notonly in22q11.2DSbut also in
schizophrenia among the general population [Waddington et al.,
2012]. The characteristic facial dysmorphism of 22q11.2DS has
been previously described clinically, anthropometrically, and using
two-dimensional (2D) facial images [Butts, 2009]. However, none
of these techniques captures and analyses facial dysmorphology in
its inherent three-dimensionality. Recently, three-dimensional
(3D) surface imaging has been applied to children with
22q11.2DS to capture facial dysmorphology, primarily in the
context of statistical discrimination from other childhood devel-
opmental syndromes, rather than quantification and specification
of 22q11.2DS dysmorphology itself [Hammond et al., 2004, 2005;
Sinderberry et al., 2013].
We have recently applied 3D surface imaging and geometric
morphometrics to quantify facial dysmorphology in adults with
schizophrenia [Hennessy et al., 2007] and bipolar disorder [Hen-
nessy et al., 2010]. The anterior brain and face evolve in embryo-
logical intimacy over early fetal life [Diewert et al., 1993; Marcucio
et al., 2005, 2011] and the developmental biology of facial mor-
phogenesis is better understood than brain morphogenesis. There-
fore, detailed, quantitative assessment of facial dysmorphology in
22q.112DS, and the extent to which it is similar to or different from
facial dysmorphology in schizophrenia, may lead to greater under-
standing of brain dysmorphogenesis in 22q11.2DS and its devel-
opmental relationship to psychosis in 22q11.2DS, schizophrenia
and bipolar disorder. Described here is the first study to investigate
facial dysmorphology in individuals with 22q11.2DS, compared to
unaffected sibling controls, using the application of 3D laser surface
imaging and geometric morphometric techniques similar to those
applied previously to schizophrenia and bipolar disorder.
MATERIALS AND METHODS
Participants
Approval for this study was obtained from the Research Ethics
Committees of Beaumont Hospital and Our Lady’s Hospital for
Sick Children, Dublin, Ireland, and Belfast City Hospital and the
Office for Research Ethics Committees, Northern Ireland, UK; for
patients aged 18 or above, written, informed consent to participa-
tionwasobtained fromthepatient,while forpatients agedunder18,
written, informed permission to participate was obtained from aparent/guardian and assent obtained from the individual. Patients
were recruited through the following sources: the National Center
for Medical Genetics, Our Lady’s Hospital for Sick Children,
Dublin; the Northern Ireland Regional Genetics Center, Belfast;
and two 22q11.2DS support groups (22q11.2DS Ireland and Max
Appeal UK).
Patients were drawn from 45 individuals having genetically
confirmed 22q11.2DS in the absence of any other chromosomal
abnormality [20males, 25 females;mean age 14.6 (SD 8.9)]; among
these 45 individualswith 22q11.2DS, 35weredenovodeletions, and
thus independent of each other, while 10 were familial, inherited
deletions and related to each other as follows: one sibling pair (2); a
father and two daughters (3); a mother, son and daughter (3); a
mother and daughter (2). Control subjects were drawn from 27
siblings of the above patients who had genetically confirmed
absence of 22q11.2DS or any other chromosomal abnormality
and were closest in age to the case [13 males, 14 females; mean
age 12.2 (SD 4.1). These cases and their sibling controls are a sub-
sample of a large, multinational study of individuals with
22q11.2DS [Schneider et al., 2014].3D Laser Surface Imaging
Facial surfaces were recorded by a single investigator (SP) using a
portable, hand-held Polhemus FastScan laser scanner, as described
previously [Hennessy et al., 2007, 2010]. A typical surface, con-
sisting of ~80 000 points [~1,60,000 triangles], has been shown
previously in detail [Hennessy et al., 2007] (Fig. 1).Facial Landmarks
Analysis proceeded on a paired, patient-control basis. While the 27
unaffected sibling controls were those closest in age to the patient,
siblings of the same sex were not always present in a given family; in
those instances [n¼ 14], the control sibling was of the other sex,
with statistical analysis controlling for effects of sex. After exclusion
of 3D laser surface images for technical inadequacy (6 of 27 showed
incomplete acquisition or patches where the surface had not been
properly reconstructed), 21 patient-control pairs were available for
analysis (patients: 8males, 13 females;meanage11.0 (SD3.8), range
6–19 years; controls: 10 males, 11 females; mean age 11.1 (SD 3.6),
range 6–22 years; patient-control pairs: 3 male-male, 5 male-
female, 6 female-female, 7 female-male).
Craniofacial shape was characterized first by manually locating
30 biologically homologous anatomical landmarks (10 on the
midline and20 as right and left counterparts of eachof 10 lateralized
points). These landmarks, shown in Figure 1 and defined more
specifically in Supplementary material I (Tables SI and SII), were
identified by a single investigator (SK), who was blind to patient-
control status. This landmark set was augmented by 480 geometri-
cally homologous semi-landmarks (also known as pseudo- or
interpolated landmarks) on curves and 1,720 on the surface to
improve description of the face in regions where anatomical land-
marks are not present. (Fig. 1) These semi-landmarks were located
by thin-plate spline (TPS) warping [Bookstein, 1989] of a symmet-
ric facial template onto each facial surface, using the anatomical
landmarks as anchoring points [Hennessy et al., 2005]. The posi-
TABLE I. Principal Component Analysis for Overall Shape Space
PC Variance explained (%) Cumulative variance (%) P
PC1 25.3 25.3 .340
PC2 16.2 41.5 < .001
PC3 11.1 52.6 .065
PC4 8.1 60.8 .740
PC5 8.0 68.7 .870
PC6 6.5 75.2 .990
Variance explained by each principal component (PC), with permutation paired t-test and
associated P values for each PC in distinguishing patients from controls.
FIG. 1. Mean facial shape across all subjects. Left, anatomical landmarks (red) and their abbreviated names with left side (L) and right side
(R) in accordance with imaging conventions; Center, anatomical landmarks (red), semilandmarks on the curves (blue) and semilandmarks on
the surface (black); Right, axis directions used in Figure 3.
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create points that are geometrically homologous with respect to the
template; this was achieved byminimizing bending energy between
the template and each facial shape, which has the effect of removing
artificial deformation [Bookstein, 1996].
Geometric Morphometrics and Visualization
Generalized Procrustes analysis (GPA) [Dryden andMardia, 1999]
was used to match the entire set of faces by minimizing the
Procrustes shape distance across location, orientation, and scale.
This also allows a mean shape to be computed, a symmetrized
versionofwhichwasusedas a template for a second stageof iterative
adjustment in order to improve accuracy. This processwas repeated
until convergence. For subsequent analysis, Procrustes shape co-
ordinates (PSC) were used, with the case-control paired structure
respected by analyzing differences and with adjustment for age and
sex by a linear regression model; see Supplementary material II.
A shape-space principal component analysis (PCA) [Hennessy
et al., 2005; Bookstein, 1991] of patient-control semi-landmark
differences was conducted; this multivariate model decomposes
overall shape signal into low-dimensional linear combinations of
high-dimensional measurements. In all cases, PCA was applied, as
described in Supplementary material II, to seek and visualize
differences between patient and control means. Statistical analyses
were performed using the R software system [RDevelopment Core
Team, 2012]. For statistical tests, a permutation approach was
adopted. This is a very useful method of performing an exact
calculation when sample sizes are modest and/or exact distribu-
tional results are difficult to derive. It involves the comparison of
observed case-control differences with a set of differences derived
from random permutations of the case-control labels. These ran-
dom permutations reflect a null hypothesis of no difference and so
they provide a reference distribution against which the difference
derived from the observed labeling can be compared. An empirical
probability (P) value can be constructed simply from the propor-
tion from the permutation sets that produce more extreme differ-
ences; 999 permutations were used.RESULTS
Among the 21 patient-control pairs, PCA identified PCs 1–6 as
explaining 75.2% of variance in overall shape space. Among these,
PC2 distinguished patients and controls [P< 0.001] (Table I). In
addition, PC6 [6.5% of variance] captured features that were
asymmetric but did not differ between patients and controls
[P¼ 0.99]; thus, they constitute subtle, intrinsic asymmetries of
human facial shape in controls [Claes et al., 2012] that are unaltered
in patients with 22q11.2DS.
These statistical findings were given biological import through
visualizations of PC2 by displaying images corresponding to the
most extreme control and case shapes. Figure 2 shows the plain
surfaces that correspond to extreme control shape and extreme case
shape. Figure 3 shows the extreme case shape with added color to
indicate the size of the change from control shape at each point on
the surface. The top row of images represents movement in the x, y,
and z directions of a face placed in an anatomical coordinate system
with the line nasion–subnasale oriented vertically. Green-toned
colors indicate little movement, while blue-toned reflect negative
values and brown-toned reflect positive values of the distances. The
exception is the x-direction, where movement is taken with respect
to the mid-line; thus, blue corresponds to narrowing and brown to
FIG. 2. Visualization of PC2 as plain surfaces for (left) extreme control shape and (right) extreme patient shape.
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ment in the direction of the surface normal (left) and the case-
control ratio of the areas of the surface triangulation (middle).
Figure 4 shows an alternative display for carefully chosen anatomi-
cal curves. In these images, cases are in red and controls in blue.FIG. 3. Visualization of PC2 as distances from extreme control shape to ex
orthogonal components of 3D distances, with the same color scale used fo
Center, differences along the y-axis in coronal-sagittal oblique view; Right,
distances in the normal direction, i.e. perpendicular to the local surface are
areas in coronal-transverse view; Right, color scale for 3D distances and tr
indicates values for patients > controls and negative [from mid-green, throUsing terminology for phenotypic variations that includes top-
ographies from Elements of Morphology [Allanson et al., 2009a;
Carey et al., 2012], these visualizations of PC2 indicate the following
features of (i) head and face [Allanson et al., 2009b]; (ii) periorbital
region [Hall et al., 2009]; (iii) nose and philtrum [Hennekam et al.,treme patient shape at each point on the facial surface. Top row shows
r all three directions: Left, differences along the x-axis in coronal view;
distances along the z-axis in sagittal view. Bottom row: Left, 3D
a, in coronal-transverse view; Center, patient-control ratios for triangle
iangle areas where positive [from mid-green, through yellow to brown]
ugh blue to purple] indicates values for patients < controls.
FIG. 4. Visualization of PC2 as selected curves for extreme
control (blue) and extreme patient (red) shapes. Left, upper lip,
mid-lip and lower lip curves in coronal view; Right, midline
silhouettes from nasion to gnathion.
PRASAD ET AL. 5332009]; and (iv) lips, mouth and oral region [Carey et al., 2009] to
statistically distinguish patients from controls.
Head and Face
Face: long face, especially above the nasal tip (Fig. 3, top-center).
Forehead: prominent and slightly broad foreheadup to the superior
limit of acquisition (Fig. 3, top row); prominence of supraorbital
ridges (Fig. 3, top-right and bottom-left). Maxilla and midface:
prominence ofmidface with slightmalar flattening that may reflect
themore prominent lower forehead andmid-face (Fig. 3, top-right
and bottom left); prominence of premaxilla (Fig. 3, bottom-left;
Fig. 4, right). Mandible: narrow jaw (narrow lower face; Fig. 3, top-
middle and top-right); retrognathia/micrognathia (Fig. 3, top-
right; Fig. 4, right). There was a very slight increase in overall facial
size in cases relative to controls (Fig. 3, bottom-center).Periorbital Region
Upward and slightly lateral displacement of the eyes (Fig. 3, top-
middle); relative prominence of superolateral orbit (Fig.3, top-
right) but relative concavity of superomedial orbit (Fig. 3,
bottom-left); downslanting palpebral fissure with slight narrowing
of eyelids (Fig. 2).Nose and Philtrum
Upward and slight forward displacement of the nose (Fig. 3, top-
right and bottom-left; Fig. 4, right); increase in nasal length (Fig. 3,top-center; Fig. 4, right); narrowing of the nasal root (Fig. 3, top-
right); prominence and roundness of the nasal tip (Fig. 3, top-right;
Fig. 4, right); narrowing of the nasal base (Fig. 2).Lips, Mouth and Oral Region
Prominence, thickness, and eversion of the vermilion (Fig. 3,
bottom-center; Fig. 4, left, right); open mouth posture (Fig. 2;
Fig. 4, right); downslant of themouth (Fig. 3, bottom-center; Fig. 4,
left).DISCUSSION
In this study we captured, analyzed and visualized over the whole
facial surface abnormalities of 3D morphology in 22q11.2DS, with
twoobjectives: First, todocument, for thefirst time in its inherent 3-
dimensionality, the quantitative dysmorphology of 22q11.2DS
craniofacies compared to sibling controls. The use of patient-
sibling controls is common in the study of 22q11.DS [Campbell
et al., 2006; Howley et al., 2012], as it controls for family environ-
ment in relation to behavioral phenotype; family resemblance is not
likely to be a major confounder, as this would favor similarities
rather than differences between patients and their unaffected
siblings. Second, to allow comparisons with the quantitative dys-
morphology of schizophrenia.
Regarding 22q11.2DS, the present findings quantify and elabo-
rate the facial characteristics described using classical clinical,
anthropometric, and 2D photographic approaches, as recently
reviewed [Butts, 2009]. Initial 3D surface imaging and geometric
morphometric studies have described some congruent findings in
clinically diagnosed 22q11.2DS compared to heterogeneous con-
trols of unconfirmed genetic status; these descriptions related to
analyses that focussed on the derivation of statistical models for
diagnostic discrimination between subjects with Williams, Smith-
Magenis, 22q11.2DS and Noonan syndrome [Hammond et al.,
2004, 2005].
In the present study, we supplemented geometric morphomet-
rics of semi-landmarks with construction and analysis of anatomi-
cal curves, geodesics, and surfaces to aid anatomical interpretation
of visualizations of PC2, the shape space that here distinguished
genetically confirmed 22q11.2DS from genetically confirmed sib-
ling controls. Additionally, we included terminology for pheno-
typic variations based on topographies from Elements of
Morphology for the standardization of humanmorphology [Allan-
son et al., 2009a; Carey et al., 2012]. Thus, our results reveal specific
dysmorphology of the periorbital region, nose and philtrum, and
lips, mouth and oral region, within more generalized dysmorphol-
ogy of the head and face.
Patients with 22q11.2DS are at increased risk for psychosis to an
extent exceeded only for monozygotic co-twins of patients with
schizophrenia [Murphy et al., 1999; Murphy, 2002; Bassett et al.,
2005]; thus, comparisons of facial dysmorphology between these
diagnostic groupshas the potential to informon shared anddistinct
aspects of developmental pathobiology. It must be taken into
account that for schizophrenia the sexes were examined separately
in patients and unrelated controls [Hennessy et al., 2007, 2010],
while here, as previously [Hammond et al., 2004, 2005], in
534 AMERICAN JOURNAL OF MEDICAL GENETICS PART A22q11.2DS opposite sexes in some patient-control sibling pairs
required sex to be statistically removed from consideration;
thus, comparisons are confined to those topographies of dysmor-
phology in schizophrenia that were most common to males and
females.
The present findings were both, similar to and distinct from our
previous 3D laser surface imaging and geometric morphometric
studies in schizophrenia [Hennessy et al., 2007, 2010]: Findings
were similar in terms of: overall widening of the upper face; lateral
displacement of the eyes/orbits; prominence of the cheeks; narrow-
ing of the lower face; narrowing of nasal prominences; posterior
displacement of the chin. Findings were distinct in terms of: facial
length (increased in 22q11.2DS (DS); decreased in schizophrenia
(SZ)); mid-face and nasal prominences (displaced upwards and
outwards inDS; less prominent in SZ); lips (more prominent inDS;
less prominent in SZ) and mouth (open mouth posture in DS;
closed mouth posture in SZ).
Before discussing the biological import of these similarities and
differences, it must be considered that while patients with schizo-
phrenia have, by definition, manifested psychotic illness from
young adulthood, those with 22q11.2DS include children who
have not yet traversed the period of risk for psychosis and in
whom sub-threshold psychotic symptoms can be difficult to iden-
tify; no patient in the present study showed florid, psychotic
symptoms.
Fundamental aspects of facial morphology are established early
in development. However, some aspects are altered during the
transition from childhood to adulthood. Increase in weight and
overall facial size with age are not likely to be major confounders:
age is taken into account in 22q11.2DS and schizophrenia analyses;
importantly, similarities and differences in facial morphology
between 22q11.2DS and schizophrenia were topographically spe-
cific, involving recessions/diminutions as well as prominences/
expansions, in a manner inconsistent with an overall effect of
age or weight.
Subjectswith 22q11.2DSare commonlydichotomized into those
who do and those who do not manifest psychotic illness subse-
quently. However, in reality the situation might be analogous to
schizophrenia, where diagnosis may reflect the crossing of an
arbitrary threshold along a dimension that extends from the
breadth of psychotic ideation in the ‘normal’ population, through
prodromal features (from brief, limited, intermittent psychotic
symptoms and the putative attenuated psychosis syndrome), to
clinical psychosis [Demjaha et al., 2009; vanOs et al., 2009; Linscott
and van Os, 2010; Waddington et al., 2012; Owoeye et al., 2013];
there is evidence that children/adolescents with 22q11.2DS show
such sub-clinical, prodromal features, the extent of which is asso-
ciated with psychosis-related psychopathological, cognitive and
structural brain changes on a continuous rather than a dichoto-
mous basis [Antshel et al., 2010; Kates et al., 2011; Armando et al.,
2012; Schneider et al., 2012]. Thus, essentially all persons with
22q11.2DS share one or more risk factor(s) for psychosis that vary
only in degree.
Therefore, the greater challenge is the extent to which the facial
dysmorphology common to 22q11.2DS and schizophrenia may
reflect a common pathobiological process associated with psycho-
sis, while the facial dysmorphology that distinguishes 22q11.2DSfrom schizophrenia might reflect other, distinct pathobiological
processes associated with distinct aspects of these disorders unre-
lated to psychosis. In recentmolecular genetic studies, 22q11.2DS is
recognized to be one of an increasing range of copy number
variations (CNVs) associated with risk, not only for intellectual
disability and psychosis, but also for autism spectrum disorder,
attention deficit hyperactivity disorder, anxiety and depression, in
association with congenital anomalies. In some individuals,
22q11.2DS may compound with a secondary CNV to result in a
more severe clinical presentation [Kaminsky et al., 2011; Doherty
et al., 2012; Girirajan et al., 2012].
At a cellular level, morphogenesis of the frontonasal prominen-
ces and forebrain are intimately regulated via epithelial-mesenchy-
mal signaling interactions: the nascent forebrain, neuroepithelium,
neural crest and facial ectoderm, from which the present surface
analyses derive, function as a developmental unit in terms of 3D
gene expression domains, with maxillary and mandibular regions
constituting distinct developmental domains [Diewert and Lozan-
off, 1993 a, b;Diewert et al., 1993;Kjaer, 1995; Schneider et al., 2001;
Echevarria et al., 2005; Marcucio et al., 2005, 2011; Tapadia et al.,
2005; Minoux and Rijli, 2010; Szabo-Rogers et al., 2010]. On this
basis, the topography of craniofacial dysmorphology in schizo-
phrenia and bipolar disorder [Hennessy et al., 2007, 2010] impli-
cates events acting particularly over a time-frame that has extreme
limits of gestational weeks 6 through 19, with a common denomi-
nator of weeks 9/10 through 14/15 of gestation [Cohen et al., 1993;
Diewert et al., 1993; Diewert and Lozanoff, 1993 a, b; Waddington
et al., 1999 a, b; Bayer and Altman, 2005]. The dysmorphology
evident here in 22q11.2DS overlaps with that in schizophrenia and
bipolar disorder, suggesting dysmorphogenic events acting over a
similar time-frame. In contrast, dysmorphology evident in
22q11.2DS distinct from those in schizophrenia and bipolar disor-
der may indicate dysmorphogenic events (a) acting over a slightly
differing time-frame, (b) having a basis in the size of the 22q11.2
deletion, and/or (c) the involvement of a secondary CNV. These
findings directly implicate dysmorphogenesis in a cerebral-cranio-
facial domain that is common to 22q11.2 DS, schizophrenia and
bipolar disorder and which may repay further clinical and genetic
interrogation in relation to the developmental origins of psychotic
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